For example, silencing USP18 has been shown to promote the antiviral innate immunity against hepatitis C virus infection [52], while pharmacological inhibition of USP14 greatly suppresses murine norovirus infection [53]. This evidence concerns the gene USP14 and hepatitis C virus infection.